Asprosin was negatively associated with BMI if adjusted for age and sex, which is not consistent with the results of the previously mentioned studies; this indicates the complex role of asprosin in obesity (27). Here, FBN1 is linked to obesity due to melanocortin 4 receptor deficiency.